Cancer

A line from Audre Lorde's book 'A Burst of Light', also known as 'The Cancer Chronicles', is circulating widely: 'Caring for myself is not self-indulgence, it is self-preservation, and that is an act of political warfare.' Lorde wrote the book while dying of breast cancer in the late 1980s, and the passage is being shared as a statement on survival and resistance.

A new study finds that infections cause roughly one in eight cancer cases worldwide. Viruses and bacteria such as HPV and H. pylori contribute to cancers that may be preventable through vaccination, screening and treatment. The findings are drawing attention to public health measures, particularly in lower-income countries where infection-related cancers are more common.

Roughly one in eight cancer cases globally is traced directly to infectious pathogens, chiefly human papillomavirus, Helicobacter pylori, and hepatitis B and C viruses. Commenters highlight that many of these cancers are preventable through vaccination, screening, and targeted antimicrobial treatment, prompting discussion about expanding access to HPV vaccines and hepatitis screening worldwide.

Researchers at the University of Arizona report that sex chromosomes play a driving role in how the body handles cancer, heart disease and ageing. The findings suggest that biological differences between males and females go beyond hormones, influencing disease risk and lifespan at the genetic level, a step that could shape future research and treatment approaches.

The role of a truncated ALK transcript as a biomarker in solid tumours is being questioned, with debate over whether it is an overhyped clinical tool or a genuinely important biological finding. ALK alterations are well established in lung cancer and other malignancies, so claims about new transcript variants are drawing attention from oncology researchers weighing their diagnostic value against uncertain biological significance.

Researchers presenting at the EADV 2026 congress report that climate change is linked to changes in skin disease patterns worldwide. Rising temperatures, increased UV exposure and shifting humidity are associated with growing or migrating cases of conditions such as eczema, skin cancer and fungal infections, prompting dermatologists to call for greater awareness and adapted healthcare planning.

A breast cancer diagnosis often brings anxiety, depression and emotional distress alongside the physical toll of treatment. Coverage highlights that patients commonly face fear of recurrence, body image struggles and isolation, and that mental health support should be treated as an integral part of cancer care rather than an afterthought for patients and families.

Cell biologist Tony Hunter, known for discovering tyrosine phosphorylation, is the subject of a new science news release circulating internationally. Hunter's work at the Salk Institute transformed cancer and cell signalling research, and items featuring him continue to draw attention from researchers following developments in molecular biology.

Experts report that roughly one in eight cancer cases worldwide are caused by infections, such as viruses and bacteria, highlighting prevention opportunities. They stress that vaccines, including those against HPV and hepatitis B, could prevent a significant share of these cancers, renewing calls for wider vaccination coverage and infection control efforts globally.

Oncologist and researcher Yan Leyfman is presenting or discussing real-world outcome data on first-line osimertinib treatment for patients with EGFR-mutated non-small cell lung cancer. The work examines how the targeted therapy performs outside clinical trials, offering insight into effectiveness and tolerability in everyday clinical practice for this common lung cancer subtype.

ESMO has opened abstract submissions for the European Lung Cancer Congress 2027, inviting researchers to submit their work for presentation. The announcement signals early preparations for one of the major international meetings on lung cancer, where new clinical data, treatment advances and research findings are typically presented to the oncology community ahead of the congress.

Barry Manilow, who recently announced a cancer diagnosis, spoke about losing his voice ahead of his upcoming tour during an appearance on 'Good Morning America'. The singer's health update has drawn attention from fans concerned about whether the tour will go ahead as planned, with coverage spreading across US news outlets.

Researchers report that the loss of a single gene allows melanoma cells to evade targeted therapies, helping explain why patients often relapse after initial treatment success. The finding points to a mechanism of drug resistance in skin cancer and may guide new combination approaches that account for this genetic loss when treating patients.

Biologists have identified a cellular pathway that appears to help colorectal cancer spread through the body. The finding offers a potential new target for treatments aimed at blocking metastasis in one of the most common cancers worldwide. Researchers say understanding how the pathway works could guide future drug development and improve patient outcomes.

Bayer is facing a new Roundup trial in Missouri while its proposed $7.25 billion settlement of US weed-killer litigation awaits a judge's ruling. The trial adds fresh pressure on the German company, which has spent years fighting tens of thousands of claims that its glyphosate-based herbicide causes cancer, and could shape how the broader settlement negotiations proceed.

The US National Cancer Institute has opened a search for a Deputy Director of its Division of Cancer Biology. The role would involve helping lead the division that oversees fundamental research into how cancer develops. The announcement is circulating among oncology researchers and cancer news outlets, with details on qualifications and applications available through the institute.

A randomized, double-blind controlled trial tested 12 months of vitamin C supplementation in 109 people with precancerous or cancerous blood disorders who were not receiving chemotherapy. Researchers found that growth of (pre)cancerous cells was unchanged in the treatment group, though the supplemented group reported fewer cases of anemia. The findings suggest vitamin C does not halt disease progression but may offer modest supportive benefits.